Compare Core Scientific Inc (CORZ) vs Stryker Corporation (SYK) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Core Scientific Inc vs Stryker Corporation — how do they compare? Core Scientific Inc trades at $15.44 (market cap $4.94B), while Stryker Corporation trades at $277.38 (market cap $106.24B). The key difference: Stryker Corporation is far larger — about 21.5× Core Scientific Inc's market cap, and Stryker Corporation pays a 1.27% dividend while Core Scientific Inc pays none. Which is the better fit depends on your goals — on Pluang, investors hold Core Scientific Inc for 20 Days and Stryker Corporation for 21 Days on average.
| CORZ | SYK | |
|---|---|---|
Market Cap | $4.94B | $106.24B |
Volume | 15,630,800 | 2,982,001 |
Sector | Technology | Health |
52-Week High | $29.16 | $388.35 |
52-Week Low | $13.57 | $269.75 |
Typical Hold Time | 20 Days | 21 Days |
Enterprise Value | $7.46B | $117.70B |
Dividend Yield | — | 1.27% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Core Scientific (CORZ) trades at $15.30, down 4.02% today amid bearish technical signals and negative earnings momentum. The stock faces fundamental challenges with a net income margin of -324.9% and three consecutive quarterly earnings misses. However, analyst sentiment remains overwhelmingly positive with 86% buy ratings and a $32.75 consensus price target, while recent executive appointments and AI infrastructure developments provide potential catalysts.
Despite current financial struggles, CORZ shows potential through its pivot to AI data center services and strong institutional support. Key risks include persistent negative profitability, high capital expenditures, and cryptocurrency market volatility. The significant gap between current price and analyst targets suggests upside potential if the company executes its AI infrastructure strategy successfully.
Stryker (SYK) trades at $277.52, up 0.77% today, amid a mixed technical and fundamental backdrop. The stock shows a bearish technical signal with key support at $274 and resistance at $279. Fundamentally, the company reported strong profitability with a 14.43% net income margin in 2026 and beat EPS estimates in two of the last three quarters. However, recent news highlights potential legal and manufacturing issues that have pressured investor sentiment.
The outlook is cautiously optimistic, with a consensus price target of $368.11 implying significant upside. Investment opportunities lie in SYK's robust earnings growth and market leadership in medical technology, but risks include ongoing legal investigations and persistent manufacturing challenges that could impact future performance.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Core Scientific Inc
Core Scientific provides digital infrastructure for Bitcoin mining and high-performance computing (HPC). It operates purpose-built data centers to support digital asset production and AI-related workloads.
Read more on CORZ →About Stryker Corporation
Stryker is a global leader in medical technology, specializing in Orthopaedics, MedSurg, and Neurotechnology. It is renowned for its highly decentralized business model, which empowers 22 specialized business units to drive innovation and category leadership. With its market-leading Mako SmartRobotics™ platform and a relentless M&A strategy, Stryker provides a comprehensive ecosystem of connected surgical tools, implants, and digital solutions that improve both clinical and financial outcomes for hospitals worldwide.
Read more on SYK →
